Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication

• Main Authors: Benjamin Seeliger (Author), Alfonso Carleo (Author), Pedro David Wendel-Garcia (Author), Jan Fuge (Author), Ana Montes-Warboys (Author), Sven Schuchardt (Author), Maria Molina-Molina (Author), Antje Prasse (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality and morbidity. Approval of antifibrotic therapy has ameliorated disease progression, but therapy response is heterogeneous and to date, adequate biomarkers predicting therapy response are lacking. In recent years...